** Carnegie raises Ambu AMBUb.CO to "buy" from "hold"
following the Danish medical devices maker's share price drop
and growth potential aided by stronger US dollar
** Ambu up 6% to November highs at 0921 GMT; if gains hold
it will see its best day in nearly 8 months
** Stock down some 38% from its 2024 highs reached in
August
** Due to a stronger US dollar, the broker expects a 4%
increase in EPS from 2025/26 onwards and a potential to return
to strong growth as soon as in Q1
** Carnegie notes Ambu's shares should go up if the growth
picks up again in Q1, as its stock is usually sensitive to
organic growth
** The broker says the second phase of the company's
"Zoom-In" strategy should set the stage for future growth, while
initially causing flat profit margins for 1-2 quarters
(Reporting by Vera Dvorakova)
((vera.dvorakova@thomsonreuters.com))